TWIN-TWIN TRANSFUSION SYNDROME ASSOCIATED MATERNAL HYPERTHYROIDISM
DOI:
https://doi.org/10.15605/jafes.040.S1.097Keywords:
twin-twin transfusion syndrome, gestational transient thyrotoxicosis, maternal hyperthyroidismAbstract
INTRODUCTION/BACKGROUND
Pregnancies complicated by twin-twin transfusion syndrome (TTTS) are associated with elevated human chorionic gonadotropin (hCG) compared to uncomplicated twin pregnancies. Studies have shown a positive correlation between hCG and free thyroxine (FT4) in TTTS, thereby increasing the risk of maternal hyperthyroidism. This case report describes a twin pregnancy complicated by TTTS, where maternal hyperthyroidism developed prior to fetoscopic laser ablation (FLA).
CASE
We present a 36-year-old female with a twin pregnancy complicated by TTTS. She was diagnosed with gestational transient thyrotoxicosis (GTT) at 10 weeks of gestation with thyroid stimulating hormone (TSH) of 0.01 mIU/L, FT4 of 24.8 pmol/L and triiodothyronine (T3) of 3.8 pmol/L. She had negative thyroid-stimulating hormone receptor antibodies and a normal neck ultrasound. Clinically, she has no goitre or thyroid eye disease. At 15 weeks of gestation, her FT4 decreased to 14.3 pmol/L while TSH remained suppressed. She did not receive any anti-thyroid drugs (ATDs) during the first trimester. She was admitted at 22 weeks of gestation for FLA due to TTTS stage 1. Upon admission, she complained of palpitations, and the cardiac monitor showed sinus tachycardia with a heart rate of 123 bpm. Her TSH was <0.008 mIU/L, FT4 was increased to 21 pmol/L and hCG of >225,000 U/L. Due to hyperthyroid symptoms, she was treated with carbimazole and beta-blocker prior to FLA. Her carbimazole dose was reduced at 25 weeks of gestation as FT4 dropped to 13.2 pmol/L. It was then discontinued at 28 weeks of gestation (FT4 11.25 pmol/L; TSH 0.11 mIU/L). She underwent emergency hysterectomy at 28 weeks of gestation due to TTTS progression to stage 4.
CONCLUSION
GTT in twin pregnancies typically resolve by the end of the first trimester. A sustained FT4 increase should raise suspicion for TTTS. ATDs should be considered due to the risk of TTTS-associated maternal hyperthyroidism, as it may persist until successful FLA.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Tean Chooi Fun , Ijaz Binti Hallaj Rahmatullah

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.




